Balloon (Foley or ATAD) vs low‐dose vaginal misoprostol
Balloon (Foley or ATAD) showed no clear difference in apgar score < 7 at 5 minutes compared with low‐dose vaginal misoprostol (low certainty).
- RR 1 [0.5, 1.97]7 studies · 941 participantsLow
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Balloon (Foley or ATAD) showed no clear difference in apgar score < 7 at 5 minutes compared with low‐dose vaginal misoprostol (low certainty).
Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with low‐dose vaginal misoprostol (low certainty).
Balloon (Foley or ATAD) probably leads to higher vaginal delivery not achieved within 24 hours compared with low‐dose oral misoprostol (moderate certainty).
Balloon (Foley or ATAD) showed no clear difference in uterine hyperstimulation with FHR changes compared with low‐dose oral misoprostol (low certainty).
Balloon (Foley or ATAD) probably leads to higher caesarean section compared with low‐dose oral misoprostol (moderate certainty).
Balloon (Foley or ATAD) showed no clear difference in serious neonatal morbidity or perinatal death compared with low‐dose oral misoprostol (low certainty).
It is very uncertain whether balloon (Foley or ATAD) changes serious maternal morbidity or death compared with low‐dose oral misoprostol (very low certainty).
Balloon (Foley or ATAD) probably leads to lower uterine hyperstimulation with FHR changes compared with vaginal prostaglandin E2 (moderate certainty).
Balloon (Foley or ATAD) showed no clear difference in apgar score < 7 after 5 minutes compared with low‐dose oral misoprostol (low certainty).
Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with low‐dose oral misoprostol (low certainty).
Balloon (Foley or ATAD) showed no clear difference in caesarean section compared with vaginal prostaglandin E2 (moderate certainty).
Balloon (Foley or ATAD) probably leads to lower serious neonatal morbidity or perinatal death compared with vaginal prostaglandin E2 (moderate certainty).
It is very uncertain whether balloon (Foley or ATAD) changes serious maternal morbidity or death compared with vaginal prostaglandin E2 (very low certainty).
Balloon (Foley or ATAD) showed no clear difference in apgar score < 7 at 5 minutes compared with vaginal prostaglandin E2 (low certainty).
Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with vaginal prostaglandin E2 (low certainty).
Balloon (Foley or ATAD) showed no clear difference in vaginal delivery not achieved in 24 hours compared with low‐dose vaginal misoprostol (low certainty).
Balloon (Foley or ATAD) probably leads to lower uterine hyperstimulation with FHR changes compared with low‐dose vaginal misoprostol (moderate certainty).